Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY) Ahead of Conference Call

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY) Ahead of Conference Call

Drugmakers slash prices in China to get on reimbursement list

November 28, 2019 2:10 AM EST

By Roxanne Liu and Brenda Goh

BEIJING/SHANGHAI (Reuters) - Drugmakers including Roche (NYSE: ROG) and Novartis' (NASDAQ: NOVN) have agreed to cut the prices of some of their newest drugs by an average of 61% in China in order to get on a national reimbursement scheme list, regulators said.

Addition to the list is likely to boost sales volume by opening up markets in smaller and less-affluent Chinese cities, but some industry insiders have cautioned that only offering deep price cuts in China could spark criticism of... More